CD44 and autoimmune thrombocytopenic purpura: found that anti-CD44 blocked the FcγR IgG binding site and thereby inhibited macrophage phagocytosis in an ITP mouse model (73), indicating that anti-CD44 could be a potentially effective alternative to IVIG.